Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1106312 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2) antibody
- Antibody type
- Monoclonal
- Description
- Ascites
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 6C2
- Vial size
- 0.1 mL
Submitted references When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer.
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer.
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Yamauchi H, Stearns V, Hayes DF
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001 Apr 15;19(8):2334-56
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001 Apr 15;19(8):2334-56
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer.
Yamauchi H, Stearns V, Hayes DF
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001 Apr 15;19(8):2334-56
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001 Apr 15;19(8):2334-56
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Mehta RR, McDermott JH, Hieken TJ, Marler KC, Patel MK, Wild LD, Das Gupta TK
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Jul;16(7):2409-16
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Jul;16(7):2409-16
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Mehta RR, McDermott JH, Hieken TJ, Marler KC, Patel MK, Wild LD, Das Gupta TK
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Jul;16(7):2409-16
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Jul;16(7):2409-16
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
